Poniard

Collaborations

Poniard Pharmaceuticals is party to a research alliance with The Scripps Research Institute, a non-profit biomedical research organization. This scientific collaborationis focusing on the discovery of novel, small-molecule, multi-targeted, protein kinase inhibitors as therapeutic agents to treat cancer. Under the agreement, Poniard Pharmaceuticals will have the option to negotiate a worldwide exclusive license to any compounds developed through the collaboration.The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations.

Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. Scripps Research is headquartered in La Jolla, California. It also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development.

 

About Poniard | Programs | Clinical Trials | Investors | News & Events | Contact